Gilad Mamlok

Mr. Gilad Mamlok has served as Sol-Gel’s Chief Financial Officer since 2017.

From 2015 to 2017, Mr. Mamlok served as the Chief Financial Officer for Medigus Ltd., a medical device company dual listed on Nasdaq and the Tel Aviv Stock Exchange, or TASE.

From 2005 to 2015, Mr. Mamlok served as Senior Vice President, global finance and accounting of Given Imaging Ltd., a medical device company dual listed on Nasdaq and TASE, acquired by Covidien plc in 2014. Prior to this, Mr. Mamlok served as Chief Financial Officer of two additional medical device companies.

Mr. Mamlok holds an MA in business economics from Tel-Aviv University and a BA in economics (magna cum laude) from Tel-Aviv University, Israel.